• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Flt3酪氨酸激酶受体基因在小鼠造血组织和神经组织中的表达。

Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues.

作者信息

deLapeyrière O, Naquet P, Planche J, Marchetto S, Rottapel R, Gambarelli D, Rosnet O, Birnbaum D

机构信息

Laboratoire d'Oncologie Moléculaire, U.119 Inserm, Marseille, France.

出版信息

Differentiation. 1995 Jun;58(5):351-9. doi: 10.1046/j.1432-0436.1995.5850351.x.

DOI:10.1046/j.1432-0436.1995.5850351.x
PMID:7622010
Abstract

The Flt3 gene encodes a tyrosine kinase receptor highly related to the Kit and Fms gene products. We have studied the expression of Flt3 by using in situ hybridization of mouse tissue sections. The results show that Flt3 RNAs are present in certain regions of lymphohematopoietic organs, placenta and nervous system. Flt3 is expressed in the medullary area of fetal and newborn thymus, in the paracortical regions of lymph nodes and in the red pulp of spleen. In placenta, labyrinthine trophoblasts express Flt3. Finally, Flt3 RNAs are found in several regions of the brain and in cerebellar Purkinje cells. Western-blot analysis showed that the FLT3 protein is present in the tissues positive for Flt3 RNA expression. Our observations allow for a comparison with the distribution of the Kit gene and analysis of a possible redundancy between KIT and FLT3 receptors.

摘要

Flt3基因编码一种与Kit和Fms基因产物高度相关的酪氨酸激酶受体。我们通过对小鼠组织切片进行原位杂交来研究Flt3的表达。结果显示,Flt3 RNA存在于淋巴造血器官、胎盘和神经系统的某些区域。Flt3在胎儿和新生儿胸腺的髓质区域、淋巴结的副皮质区域以及脾脏的红髓中表达。在胎盘中,迷路滋养层细胞表达Flt3。最后,在大脑的几个区域以及小脑浦肯野细胞中发现了Flt3 RNA。蛋白质免疫印迹分析表明,FLT3蛋白存在于Flt3 RNA表达阳性的组织中。我们的观察结果有助于与Kit基因的分布进行比较,并分析KIT和FLT3受体之间可能存在的冗余情况。

相似文献

1
Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues.Flt3酪氨酸激酶受体基因在小鼠造血组织和神经组织中的表达。
Differentiation. 1995 Jun;58(5):351-9. doi: 10.1046/j.1432-0436.1995.5850351.x.
2
Developmental expression of flt3 mRNA in the mouse brain.Flt3 mRNA在小鼠大脑中的发育表达。
J Mol Neurosci. 1993 Winter;4(4):235-43. doi: 10.1007/BF02821555.
3
Loss of flk-2/flt3 expression during commitment of multipotent mouse hematopoietic progenitor cells to the mast cell lineage.多能小鼠造血祖细胞向肥大细胞谱系定向分化过程中flk-2/flt3表达的丧失。
Exp Hematol. 1997 Jul;25(7):620-8.
4
Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase.FLT3/FLK2受体酪氨酸激酶的生化特性及转化潜能分析
Oncogene. 1993 Apr;8(4):909-18.
5
Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.从flt3+多能骨髓祖细胞分化出NK1.1+、Ly49+自然杀伤细胞。
J Immunol. 1999 Sep 1;163(5):2648-56.
6
Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.Flt3/Flk-2和c-Kit对于成年小鼠骨髓中B淋巴细胞祖细胞的增殖并非必需。
Exp Hematol. 1998 Jun;26(6):478-88.
7
Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.Fms样酪氨酸激酶3催化结构域可在FDC-P1细胞中传导增殖信号,该信号在性质上与c-Fms传递的信号相似。
Cell Growth Differ. 1994 May;5(5):549-55.
8
The FLT3 tyrosine kinase receptor inhibits neural stem/progenitor cell proliferation and collaborates with NGF to promote neuronal survival.FLT3酪氨酸激酶受体抑制神经干/祖细胞增殖,并与神经生长因子协同作用以促进神经元存活。
Mol Cell Neurosci. 2001 Oct;18(4):381-93. doi: 10.1006/mcne.2001.1033.
9
Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.血管内皮生长因子受体-1(flt-1)及其配体的协同表达提示了对小鼠血管发育的旁分泌调节。
Dev Dyn. 1995 Nov;204(3):228-39. doi: 10.1002/aja.1002040303.
10
Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase.小鼠Flt3受体酪氨酸激酶羧基末端的底物特异性及磷脂酰肌醇-3激酶假定结合位点的鉴定。
Oncogene. 1994 Jun;9(6):1755-65.

引用本文的文献

1
Visualizing the Cellular and Subcellular Distribution of Fms-like Tyrosine Kinase 3 (Flt3) and Other Neuronal Proteins Using Alkaline Phosphatase (AP) Immunolabeling.利用碱性磷酸酶(AP)免疫标记可视化Fms样酪氨酸激酶3(Flt3)和其他神经元蛋白的细胞及亚细胞分布
Int J Mol Sci. 2025 Mar 4;26(5):2284. doi: 10.3390/ijms26052284.
2
A germline FLT3 variant in aplastic anemia.再生障碍性贫血中的一种胚系FLT3变异体。
Biomark Res. 2025 Jan 7;13(1):4. doi: 10.1186/s40364-024-00717-3.
3
Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery.
带有关闭开关的同种异体 FLT3 CAR T 细胞对 AML 具有强大的活性,并可被清除以加速骨髓恢复。
Mol Ther. 2020 Oct 7;28(10):2237-2251. doi: 10.1016/j.ymthe.2020.06.022. Epub 2020 Jun 19.
4
Selectively targeting FLT3-ITD mutants over FLT3-wt by a novel inhibitor for acute myeloid leukemia.一种用于急性髓性白血病的新型抑制剂对FLT3-ITD突变体的靶向性优于FLT3野生型。
Haematologica. 2021 Feb 1;106(2):605-609. doi: 10.3324/haematol.2019.244186.
5
Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice.抑制神经元FLT3受体酪氨酸激酶可减轻小鼠外周神经性疼痛。
Nat Commun. 2018 Mar 12;9(1):1042. doi: 10.1038/s41467-018-03496-2.
6
Discovery of a Diaminopyrimidine FLT3 Inhibitor Active against Acute Myeloid Leukemia.一种对急性髓系白血病有效的二氨基嘧啶FLT3抑制剂的发现。
ACS Omega. 2017 May 31;2(5):1985-2009. doi: 10.1021/acsomega.7b00144. Epub 2017 May 10.
7
Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.非核心结合因子急性髓系白血病患者中枢神经系统复发风险的相关因素。
Am J Hematol. 2017 Sep;92(9):924-928. doi: 10.1002/ajh.24799. Epub 2017 Jul 19.
8
Abnormal expression of long non-coding RNAs in myocardial infarction.长链非编码RNA在心肌梗死中的异常表达。
Heart Vessels. 2017 Oct;32(10):1253-1261. doi: 10.1007/s00380-017-0990-7. Epub 2017 May 23.
9
The Biology and Targeting of FLT3 in Pediatric Leukemia.FLT3 在儿科白血病中的生物学和靶向治疗。
Front Oncol. 2014 Sep 23;4:263. doi: 10.3389/fonc.2014.00263. eCollection 2014.
10
Profile of pacritinib and its potential in the treatment of hematologic disorders.帕西替尼概况及其在血液系统疾病治疗中的潜力。
J Blood Med. 2014 Aug 19;5:143-52. doi: 10.2147/JBM.S51253. eCollection 2014.